We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Anti-Retrovirals for Kaposi's Sarcoma (ARKS)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00444379
First Posted: March 7, 2007
Last Update Posted: August 20, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
National Institutes of Health (NIH)
Gilead Sciences
Abbott
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
University of California, San Francisco
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2012
  Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)